UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2016 2016-05-09 Future report Set alerts
Q4 2015 2016-02-09 0.00 0.00
Q3 2015 2015-11-09 0.00 -0.27
Q2 2015 2015-08-11 0.00 -0.69
Q1 2015 2015-05-15 0.00 -0.71
Q4 2014 2015-03-30 0.00 -0.55
Q3 2014 2014-11-12 0.00 -0.40
Q2 2014 2014-08-07 0.00 -0.38
Q1 2014 2014-05-13 0.00 -0.41
Q4 2013 2014-03-31 0.00 -0.35

Ratings

2015-06-30 Reiterated Rating BMO Capital Markets Market Perform
2015-06-29 Reiterated Rating HC Wainwright Hold
2015-06-02 Reiterated Rating HC Wainwright Hold
2015-05-15 Reiterated Rating HC Wainwright Hold
2015-04-28 Downgrade HC Wainwright Buy to Neutral
2015-04-27 Downgrade Stifel Nicolaus Buy to Hold
2015-04-27 Downgrade Wedbush Outperform to Neutral
2015-04-27 Downgrade Roth Capital Buy to Neutral $2.00
2015-04-22 Initiated Coverage BMO Capital Markets Market Perform to Market Perform $15.00 to $15.00
2015-04-07 Initiated Coverage HC Wainwright Buy $31.00
2015-03-05 Initiated Coverage Roth Capital Buy $70.00
2014-10-13 Initiated Coverage Credit Suisse Outperform $20.00
2014-02-24 Initiated Coverage Barclays Overweight $15.00
2014-02-24 Initiated Coverage Stifel Nicolaus Buy $16.00
2014-02-24 Initiated Coverage Wedbush Outperform $17.00
2015-06-30 Reiterated Rating BMO Capital Markets Market Perform
2015-06-29 Reiterated Rating HC Wainwright Hold
2015-06-02 Reiterated Rating HC Wainwright Hold
2015-05-15 Reiterated Rating HC Wainwright Hold
2015-04-28 Downgrade HC Wainwright Buy to Neutral

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CLDN 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
Enterprise Partners Management LLC 10.52%  (1950184) CLDN /
PFIZER INC 9.68%  (1794803) AQXP / CLDN / FLXN /
Lundbeckfond Invest A/S 9.42%  (1745683) CLDN /
Kordel Johan 9.42%  (1745683) CLDN /
Novartis Bioventures Ltd 8.37%  (1551721) AKBA / CLDN / MRNA / PIP / TKAI /
Funder Joshua 6.44%  (1194204) CLDN /
Foley Todd 5.76%  (1066775) CLDN / EPRS / PETX /
NARACHI MICHAEL 0.34%  (62500) AMAG / CLDN / OREX /
Cory David A President and CEO 0.32%  (58451) CLDN /
Glenn Jeffrey S 0.17%  (31355) CLDN /
WIKLUND FREDRIK VP Corp Dvlpmnt & Invs Rltns 0.11%  (20000) CLDN /
Shaffer James P Chief Business Officer 0.03%  (5620) CLDN / HALO /
ZSEBO KRISZTINA M Chief Executive Officer 0.02%  (3125) CLDN /
LABA REBECQUE J VP Finance & Administration 0.02%  (2895) CLDN /
WELCH JAMES H Chief Financial Officer 0.01%  (2500) ACRX / CLDN /
TAKEYA RYAN K VP, Manufacturing 0.01%  (1432) CLDN /
RUDY JEFFREY J VP, Clinical Operations 0.01%  (1024) CLDN /

Comments